Christian Juhl Terkelsen
Latest contributions
Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.
Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice
21 May 2025 – From EuroPCR 2025
This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
Learnings from LANDMARK and Compare-TAVI at 3 years
22 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Andreas Baumbach, Christian Juhl Terkelsen and Didier Tchetche reviewed the latest findings from the LANDMARK and Compare-TAVI 1 trials—both focused on the performance of the Myval balloon-expandable valve.
LANDMARK compared Myval and Myval Octacor to leading self-expanding valves in a randomised controlled trial. At...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead in TAVI innovation by exploring the advanced balloon-expandable Myval THV series. This session highlights the latest clinical data, optimal sizing and implantation techniques, and valuable real-world insights, including long-term follow-up results.
Compare TAVI - Top Late Breaking Trial at PCR London Valves 2024
26 Nov 2024 – From PCR London Valves 2024
Chiara De Biase and Christian Terkelsen review the one-year results of the Compare TAVI randomized study, which set a benchmark for evaluating the performance and safety of new transcatheter heart valves (THVs) compared to best-in-practice THVs. The findings revealed that the Myval THV series was non-inferior...
Featured cases - Challenging TAVI scenarios
26 Nov 2024 – From PCR London Valves 2024
Explore this curated collection of challenging TAVI cases from PCR London Valves 2024. Discover innovative techniques and strategies employed to navigate complex anatomies, including TAVR with coronary protection, 3D ICE-guided antegrade TAVR, no-contrast TAVI in end-stage renal disease, and snare-assisted TAVI for precision. Gain insights into...
The top clinical cases in interventional cardiology
25 Nov 2024 – From PCR London Valves 2024
Curious about the latest in interventional cardiology? Don't miss this video!
You'll discover groundbreaking techniques for complex conditions, from treating mitral regurgitation after healed endocarditis to repairing the tricuspid valve in dextrocardia. You'll also see the latest advances (including the SAPIEN 3 Tendyne device) and gain expert...
TAVI innovations: latest breakthroughs from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.
Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...
Align for the future with next-generation balloon expandable THV technology
15 May 2024 – From EuroPCR 2024
In this session, explore the next-generation balloon-expandable Myval Octacor THV, focusing on its key features, procedural impact, and potential clinical benefits. Understand the procedural steps for planning and implanting it, especially for intermediate and extra-large sizes, using the Octalign technique. Learn about the unmet clinical need...
Interventions for multiple valve disease
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover innovative strategies for managing multiple valve diseases: witness the strategic staging of treatments using two distinct devices for mitigating mitral and tricuspid regurgitation, navigate the challenges encountered in a patient presenting with severe mitral and tricuspid regurgitation and unable for edge-to-edge procedures,...
Unmet clinical need & relevance of intermediate & XL sizes in TAVI
08 Jan 2024 – From PCR London Valves 2023
In this roundtable discussion, Patrick Serruys, Andreas Baumbach, and Christian Juhl Terkelsen explore the innovative concept of intermediate sizes and extra-large valves. They introduce a new valve which is another step forward in addressing the unmet needs of the interventional cardiovascular community.
This interview was filmed at...
Essentials of lifetime management of TAVI patients
20 Nov 2023 – From PCR London Valves 2023
In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.
TAVI with challenging femoral access
19 Nov 2023 – From PCR London Valves 2023
Learn how to perform transfemoral TAVI using orbital atherectomy, insert a self-expanding valve through a tortuous and calcified aorta, or navigate through calcified vessels or kinked aorta thanks to the techniques presented in this session, among others.
Matching patient to TAVI prosthesis - Is there a better way?
04 Mar 2023 – From AfricaPCR 2023
In this AfricaPCR 2023 session, analyse several complex TAVI cases and explore why and how THV design elements should help optimise TAVI clinical outcomes.
